Observed versus expected morbidity and mortality in patients undergoing mitral valve repair

OBJECTIVES: Mitral valve repair (MVP) is the gold standard treatment for degenerative mitral regurgitation. With the expansion of transcatheter technologies, this study compares the outcome of MVP in low-risk and non-low-risk patients to serve as a benchmark. METHODS: This retrospective, single-inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Newell, Paige, Tartarini, Richard, Hirji, Sameer, Harloff, Morgan, McGurk, Siobhan, Cherkasky, Olena, Kaneko, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adult Cardiac
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553224/
https://www.ncbi.nlm.nih.gov/pubmed/36205629
http://dx.doi.org/10.1093/icvts/ivac241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553224/
https://www.ncbi.nlm.nih.gov/pubmed/36205629
http://dx.doi.org/10.1093/icvts/ivac241

Ejemplares similares